Clinical Trials Logo
  1. Home
  2. Colorectal Cancer Stage III
  3. NCT04304209

Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer

Colorectal Cancer Stage III Clinical Trial

Official title:
Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer

Clinical Trial Summary

In this study, participants with locally advanced rectal cancer patients will be treated according to MMR/MSI status. There will be two cohorts in this study: Cohort A and Cohort B. For Cohort A, dMMR or MSI-H patients will receive 4 cycles of neoadjuvant Pd1 antibody Sintilimab,followed by one of the following treatments: (1) surgery and adjuvant treatment, (2）another 4 cycles of sintilimab, followed by radical surgery or observation (only for cCR) . For Cohort B, pMMR/MSS/MSI-L patients will be randomized to receive neoadjuvant chemoradiotherapy ± four cycles of Pd1 antibody Sintilimab，followed by one of the following treatments: (1) curative surgery and four cycles of adjuvant chemotherapy;(2)four cycles of chemotherapy then observation (only cCR after neoadjuvant therapy)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04304209
Study type Interventional
Source Sun Yat-sen University
Contact
Status Active, not recruiting
Phase Phase 2
Start date October 28, 2019
Completion date October 18, 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT01570452 - Matrilysin Expression in Different Stages of Colorectal Tumors N/A
Active, not recruiting NCT04398446 - Effect of Hemp-CBD on Patients With CIPN Phase 2
Recruiting NCT04486378 - A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer Phase 2
Recruiting NCT04264676 - Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer Phase 2
Recruiting NCT06314958 - Stage II/III Colorectal Cancer Recurrence
Recruiting NCT06342440 - Early Detection of Advanced Adenomas and Colorectal Cancer
Recruiting NCT04714814 - Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
Recruiting NCT05898789 - Virtual Rehabilitation for Cancer Survivors N/A
Completed NCT01356264 - Multimodal Prehabilitation for Colorectal Surgery Phase 2
Recruiting NCT04813627 - Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy
Recruiting NCT03448549 - SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients Phase 3
Recruiting NCT03904537 - A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer Phase 1/Phase 2
Not yet recruiting NCT05131243 - the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer N/A
Recruiting NCT06111105 - Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
Recruiting NCT06076811 - DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
Recruiting NCT06342401 - Early Onset Colorectal Cancer Detection
Completed NCT06271980 - Early-Onset Colorectal Cancer Recurrence